Gina Lin

机构：University School, Case Western Reserve University

发表论文 15 篇 · 总被引 715 次 · h-index 7

代表论文

Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial (2019 · The Lancet Infectious Diseases · 被引 354)
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial (2018 · Clinical Infectious Diseases · 被引 174)
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial (2020 · Clinical Infectious Diseases · 被引 80)
Characterization of very-low density lipoprotein particle diameter dynamics in relation to egg production in a passerine bird (2007 · Journal of Experimental Biology · 被引 35)
Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries (2015 · Malaria Journal · 被引 27)
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia (2021 · Journal of Antimicrobial Chemotherapy · 被引 25)